New drug trial aims to outperform chemo for tough prostate cancer
NCT ID NCT07365995
Summary
This study is testing if an experimental drug called BNT324 helps men with advanced prostate cancer live longer or live longer without their cancer getting worse, compared to the current standard chemotherapy. It will involve about 736 men whose cancer has spread and stopped responding to standard hormone-blocking treatments. Participants will be randomly assigned to receive either BNT324 or the standard chemotherapy combination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.